IndraLab
Statements
Hydroxychloroquine activates sulfasalazine. 1 / 1
|
1
reach
"Among patients with RA, PSA, or undifferentiated arthritis, epicardial ICIs were observed in 3 (50%) of 6 patients treated with methotrexate, in the 1 patient (100%) treated with tumor necrosis factor-alpha inhibitors in combination with methotrexate, in 3 (100%) of 3 patients treated with sulfasalazine, in the 1 patient (100%) treated with hydroxychloroquine, and in 16 (55%) of 29 patients not currently receiving DMARDs."